CK Life Sciences Int'l., (Holdings) Inc.

HKEX:0775.HK

0.46 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q4
Revenue 2,635.8512,743.6052,579.1282,735.0082,540.5822,763.9242,638.3882,563.0142,379.532,370.512,596.5142,691.7822,541.212,379.1762,313.9572,340.8732,527.6672,470.0462,449.2632,537.2512,416.7922,489.7522,481.1750000000
Cost of Revenue 1,836.4172,252.0792,122.9472,201.6132,086.1242,286.4672,171.7272,247.2761,936.1551,679.0321,781.161,808.6051,690.0231,625.2171,524.1051,571.9571,634.0851,591.3051,586.1571,625.4691,588.2521,611.4541,617.6590000000
Gross Profit 799.434491.526456.181533.395454.458477.457466.661315.738443.375691.478815.354883.177851.187753.959789.852768.916893.582878.741863.106911.782828.54878.298863.5160000000
Gross Profit Ratio 0.3030.1790.1770.1950.1790.1730.1770.1230.1860.2920.3140.3280.3350.3170.3410.3280.3540.3560.3520.3590.3430.3530.3480000000
Reseach & Development Expenses 72.90474.94370.93199.76658.76959.55897.711100.08849.68581.97640.308120.0931.745120.91553.36887.57282.90388.88794.238109.32781.496122.325103.1780000000
General & Administrative Expenses 000000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000000
SG&A 318.099316.599261.386325.447263.95350.441199.796333.91190.677599.779505.32263.595261.147247.853259.466258.77262.903247.544244.175253.712244.274247.045242.9180000000
Other Expenses 000000000000000000000000000000
Operating Expenses 391.003391.542332.317425.213322.719409.999297.507433.998240.362681.755545.628611.719583.53582.626544.286593.663613.383785.583605.244710.164607.117703.129640.5940000000
Operating Income 408.43199.984123.864108.182131.73967.458169.154-118.26203.0139.723269.726128.178254.551-32.429215.03566.08250.955123.469155.208129.2181.233129.504191.480000000
Operating Income Ratio 0.1550.0360.0480.040.0520.0240.064-0.0460.0850.0040.1040.0480.1-0.0140.0930.0280.0990.050.0630.0510.0750.0520.0770000000
Total Other Income Expenses Net -403.437-88.501-67.096-8.958-26.12331.148-30.726109.908-77.015-0.439-62.42678.062-39.565160.24-12.85364.629-19.503-80.05750.96121.965-11.268-4.452-12.8030000000
Income Before Tax 4.99411.48356.76899.224105.61698.606138.428-8.352125.9989.284207.3206.24214.986127.811202.182130.709231.45243.412206.169151.165169.965125.052178.6770000000
Income Before Tax Ratio 0.0020.0040.0220.0360.0420.0360.052-0.0030.0530.0040.080.0770.0850.0540.0870.0560.0920.0180.0840.060.070.050.0720000000
Income Tax Expense 3.99331.39619.93831.92240.9936.93738.501-45.61139.509-3.77931.25382.01538.52220.31729.13154.9739.97636.66626.78733.26615.11238.21730.9660000000
Net Income 1.001-19.66236.91266.84365.1262.407100.39437.79387.44110.482171.25392.069170.93288.128170.27465.541187.41940.191178.666116.95146.60889.08139.9280000000
Net Income Ratio 0-0.0070.0140.0240.0260.0230.0380.0150.0370.0040.0660.0340.0670.0370.0740.0280.0740.0160.0730.0460.0610.0360.0560000000
EPS 0-0.0020.0040.0070.0070.0070.010.0040.0090.0010.0180.010.0180.0090.0180.0070.020.0040.0190.0120.0150.0090.0150000000
EPS Diluted 0-0.0020.0040.0070.0070.0070.010.0040.0090.0010.0180.010.0180.0090.0180.0070.020.0040.0190.0120.0150.0090.0150000000
EBITDA 234.244147.766172.202158.083183.414123.46227.44-61.893253.89362.093317.261236.368284.65441.245286.208167.206284.854214.913218.802232.049214.687228.773228.7080000000
EBITDA Ratio 0.0890.0540.0670.0580.0720.0450.086-0.0240.1070.0260.1220.0880.1120.0170.1240.0710.1130.0870.0890.0910.0890.0920.0920000000